The implication of our data would be enormous because natural nontoxic agents could be useful for the down-regulation of FoxM1 mediated via upregulation of miR-200, and our data further suggest that such strategy could in fact be useful for sensitization of drug-resistant breast cancer cells to other agents that are not very effective by themselves, such as Herceptin. Here, FOXM1 is linked to breast carcinoma.